Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 19, 2018 07:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Expands CAR-TXpress™ Intellectual Property Portfolio with Filing of New Patent Covering Cell Activation & Transduction

RANCHO CORDOVA, Calif., March 19, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based...
March 15, 2018 07:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics to Announce Financial Results for the Transition Period From July 1, 2017 to December 31, 2017 on March 22

RANCHO CORDOVA, Calif., March 15, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
March 14, 2018 07:00 ET | Source: Cesca Therapeutics Inc.

Cesca’s Device Subsidiary, ThermoGenesis, Expands into CAR-T Related Contract Development and Manufacturing (CDMO) Services

RANCHO CORDOVA, Calif., March 14, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based...
March 06, 2018 07:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Inc. to Present at BIO-Europe Spring® 2018

RANCHO CORDOVA, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL) today announced that Joe Balagot, senior vice president of corporate development, will...
February 28, 2018 07:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Inc. to Present at the 8th Spring Meeting of the International Society for BioProcess Technology (ISBiotech)

RANCHO CORDOVA, Calif., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL) a market leader in automated cell processing and point-of-care, autologous cell-based...
February 26, 2018 07:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Inc. Announces Commercial Launch of AXP® II System for Advanced Cord Blood Processing

RANCHO CORDOVA, Calif., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL) a market leader in automated cell processing and point-of-care, autologous cell-based...
February 05, 2018 07:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Inc. to Present at the BIO CEO & Investor Conference on Monday, February 12, 2018

RANCHO CORDOVA, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL) a market leader in automated cell processing and point-of-care, autologous cell-based...
January 02, 2018 07:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Inc. to Present at Biotech Showcase on Tuesday, January 9, 2018

RANCHO CORDOVA, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL) a market leader in automated cell processing and point-of-care, autologous cell-based...
November 30, 2017 07:30 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Inc. to Participate in the LD Micro 10th Annual Main Event on Thursday, December 7, 2017

RANCHO CORDOVA, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL) a market leader in automated cell processing and point-of-care, autologous cell-based...
November 29, 2017 09:07 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Inc. Announces Pricing of Public Offering of up to 900,000 shares of Common Stock

RANCHO CORDOVA, Calif., Nov. 29, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL) a market leader in automated cell processing and point-of-care, autologous cell-based...